Toxicity of arsenite and thio-DMAV after long-term (21 days) incubation of human urothelial cells: Cytotoxicity, genotoxicity and epigenetics

Toxicology Research

Volumn 3, Issue 6, 2014, Pages 456-464

  Unterberg, Marlies ^a,b   Leffers, Larissa ^a   Hübner, Florian ^a   Humpf, Hans Ulrich ^a   Lepikhov, Konstantin ^c   Walter, Jörn ^c   Ebert, Franziska ^b   Schwerdtle, Tanja ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; ARSENIC TRIOXIDE; DRUG METABOLITE; GLUTATHIONE; GLUTATHIONE DISULFIDE; THIO DIMETHYLARSINIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CYTOTOXICITY; DNA METHYLATION; EPIGENETICS; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MASS SPECTROMETRY; UROTHELIUM;

EID: 84908070882     PISSN: 2045452X     EISSN: 20454538     Source Type: Journal    
DOI: 10.1039/c4tx00036f     Document Type: Article

References (67)

1. I. P. Pogribny and I. Rusny, in Epigenetic Alterations in Oncogenesis Advances in Experimental Medicine and Biology 754, ed. A. R. Karpf, Springer, Berlin, 2013, vol. 754, pp. 215-232.
2. D. Deobagkar, in Toxicology and Epigenetics, ed. S. C. Sahu, Wiley, Chichester, UK, 2012, pp. 25-50.
3. B. Sadikovic, K. Al-Romaih, J. A. Squire and M. Zielenska, Curr. Genomics, 2008, 9, 394-408.
4. J. Sandoval and M. Esteller, Curr. Opin. Genet. Dev., 2012, 22, 50-55.
5. IARC, IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, Lyon, France, 1987.
6. IARC, A review of human carcinogens - Part C: Arsenic, metals, fibres and dusts, IARC Monographs, Lyon, France, 2012.
7. EFSA, Panel on Contaminants in the Food Chain (CONTAM), European Food Safety Authority (EFSA), Scientific Opinion on Arsenic in Food, EFSA J., 2009, 7(1-198), 1351.
8. A. Arita and M. Costa, Metallomics, 2009, 1, 222-228.
9. J. F. Reichard and A. Puga, Epigenomics, 2010, 2, 87-104.
10. J. C. States, A. Barchowsky, I. L. Cartwright, J. F. Reichard, B. W. Futscher and R. C. Lantz, Environ. Health Perspect., 2011, 119, 1356-1363.
11. M. F. Hughes, B. D. Beck, Y. Chen, A. S. Lewis and D. J. Thomas, Toxicol. Sci., 2011, 123, 305-332.
12. H. H. Wang, M. M. Wu, M. W. Chan, Y. S. Pu, C. J. Chen and T. C. Lee, Arch. Toxicol., 2014, Feb 24 Epub ahead of print.
13. J. F. Reichard, M. Schnekenburger and A. Puga, Biochem. Biophys. Res. Commun., 2007, 352, 188-192.
14. S. B. Baylin and J. G. Herman, Trends Genet, 2000, 16, 168-174.
15. R. Martinez-Zamudio and H. C. Ha, Epigenetics, 2011, 6, 820-827.
16. X. Ren, C. M. McHale, C. F. Skibola, A. H. Smith, M. T. Smith and L. Zhang, Environ. Health Perspect., 2011, 119, 11-19.
17. C. J. Marsit, M. R. Karagas, H. Danaee, M. Liu, A. Andrew, A. Schned, H. H. Nelson and K. T. Kelsey, Carcinogenesis, 2006, 27, 112-116.
18. C. J. Marsit, M. R. Karagas, A. Schned and K. T. Kelsey, Annal. N. Y. Acad. Sci., 2006, 1076, 810-821.
19. M. Bartel, F. Ebert, L. Leffers, U. Karst and T. Schwerdtle, J. Toxicol., 2011, 2011, 373141.
20. F. Ebert, L. Leffers, T. Weber, S. Berndt, A. Mangerich, S. Beneke, A. Burkle and T. Schwerdtle, J. Trace Elem. Med. Biol., 2014, 28(2), 138-146.
21. L. Leffers, M. Unterberg, M. Bartel, C. Hoppe, I. Pieper, J. Stertmann, F. Ebert, H. U. Humpf and T. Schwerdtle, Toxicology, 2013, 305, 109-119.
22. H. Naranmandura, M. W. Carew, S. Xu, J. Lee, E. M. Leslie, M. Weinfeld and X. C. Le, Chem. Res. Toxicol., 2011, 24, 1586-1596.
23. H. Naranmandura, Y. Ogra, K. Iwata, J. Lee, K. T. Suzuki, M. Weinfeld and X. C. Le, Toxicol. Appl. Pharmacol., 2009, 238, 133-140.
24. M. Wossidlo, J. Arand, V. Sebastiano, K. Lepikhov, M. Boiani, R. Reinhardt, H. Scholer and J. Walter, EMBO J., 2010, 29, 1877-1888.
25. K. E. Eblin, M. E. Bowen, D. W. Cromey, T. G. Bredfeldt, E. A. Mash, S. S. Lau and A. J. Gandolfi, Toxicol. Appl. Pharmacol., 2006, 217, 7-14.
26. B. W. Futcher, in Epigenetic Alterations in Oncogenesis Advances in Experimental Medicine and Biology 754, ed. A. R. Karpf, Springer, Berlin, 2013, vol. 754, pp. 179-194.
27. J. Sandhu, B. Kaur, C. Armstrong, C. J. Talbot, W. P. Steward, P. B. Farmer and R. Singh, J. Chromatogr., B: Anal. Technol. Biomed. Life Sci., 2009, 877, 1957-1961.
28. L. Song, S. R. James, L. Kazim and A. R. Karpf, Anal. Chem., 2005, 77, 504-510.
29. X. Wang, Y. Suo, R. Yin, H. Shen and H. Wang, J. Chromatogr., B: Anal. Technol. Biomed. Life Sci., 2011, 879, 1647-1652.
30. M. F. Paz, M. F. Fraga, S. Avila, M. Guo, M. Pollan, J. G. Herman and M. Esteller, Cancer Res., 2003, 63, 1114-1121.
31. L. Leffers, F. Ebert, M. S. Taleshi, K. A. Francesconi and T. Schwerdtle, Mol. Nutr. Food Res., 2013, 57, 1270-1282.
32. M. Fenech, Mutat. Res., 2000, 455, 81-95.
33. M. Fenech, M. Kirsch-Volders, A. T. Natarajan, J. Surralles, J. W. Crott, J. Parry, H. Norppa, D. A. Eastmond, J. D. Tucker and P. Thomas, Mutagenesis, 2011, 26, 125-132.
34. L. Schermelleh, F. Spada, H. P. Easwaran, K. Zolghadr, J. B. Margot, M. C. Cardoso and H. Leonhardt, Nat. Methods, 2005, 2, 751-756.
35. L. Schermelleh, F. Spada and H. Leonhardt, Curr. Protoc. Cell Biol., 2008, ch. 22, unit 22.12.
36. M. Oka, A. M. Meacham, T. Hamazaki, N. Rodic, L. J. Chang and N. Terada, Oncogene, 2005, 24, 3091-3099.
37. A. Portela and M. Esteller, Nat. Biotechnol., 2010, 28, 1057-1068.
38. L. Wild and J. M. Flanagan, Biochim. Biophys. Acta, 2010, 1806, 50-57.
39. M. Ehrlich and M. Lacey, in Epigenetic Alterations in Oncogenesis Advances in Experimental Medicine and Biology 754, ed. A. R. Karpf, Springer, Berlin, 2013, vol. 754, pp. 31-56.
40. M. Ehrlich, Oncogene, 2002, 21, 5400-5413.
41. A. G. Rivenbark and W. B. Coleman, in Toxicology and Epigenetics, ed. S. C. Sahu, Wiley, Chichester, UK, 2012, pp. 317-338.
42. C. Q. Zhao, M. R. Young, B. A. Diwan, T. P. Coogan and M. P. Waalkes, Proc. Natl. Acad. Sci. U. S. A., 1997, 94, 10907-10912.
43. J. F. Coppin, W. Qu and M. P. Waalkes, J. Biol. Chem., 2008, 283, 19342-19350.
44. T. J. Jensen, P. Novak, K. E. Eblin, A. J. Gandolfi and B. W. Futscher, Carcinogenesis, 2008, 29, 1500-1508.
45. T. J. Jensen, P. Novak, S. M. Wnek, A. J. Gandolfi and B. W. Futscher, Toxicol. Appl. Pharmacol., 2009, 241, 221-229.
46. L. Benbrahim-Tallaa, R. A. Waterland, M. Styblo, W. E. Achanzar, M. M. Webber and M. P. Waalkes, Toxicol. Appl. Pharmacol., 2005, 206, 288-298.
47. M. J. Mass and L. Wang, Mutat. Res., 1997, 386, 263-277.
48. R. Jaenisch and A. Bird, Nat. Genet., 2003, 33(Suppl), 245-254.
49. R. J. Klose and A. P. Bird, Trends Biochem. Sci., 2006, 31, 89-97.
50. J. Y. Li, M. T. Pu, R. Hirasawa, B. Z. Li, Y. N. Huang, R. Zeng, N. H. Jing, T. Chen, E. Li, H. Sasaki and G. L. Xu, Mol. Cell Biol., 2007, 27, 8748-8759.
51. H. Y. Fu, J. Z. Shen, Y. Wu, S. F. Shen, H. R. Zhou and L. P. Fan, Oncol. Rep., 2010, 24, 335-343.
52. X. Cui, T. Wakai, Y. Shirai, N. Yokoyama, K. Hatakeyama and S. Hirano, Hum. Pathol., 2006, 37, 298-311.
53. S. A. Weitzman, P. W. Turk, D. H. Milkowski and K. Kozlowski, Proc. Natl. Acad. Sci. U. S. A., 1994, 91, 1261-1264.
54. V. Valinluck and L. C. Sowers, Cancer Res., 2007, 67, 946-950.
55. F. Ebert, A. Weiss, M. Bultemeyer, I. Hamann, A. Hartwig and T. Schwerdtle, Mutat. Res., 2011, 715, 32-41.
56. K. A. Bailey, M. C. Wu, W. O. Ward, L. Smeester, J. E. Rager, G. Garcia-Vargas, L. M. Del Razo, Z. Drobna, M. Styblo and R. C. Fry, J. Biochem. Mol. Toxicol., 2013, 27, 106-115.
57. E. Mosharov, M. R. Cranford and R. Banerjee, Biochemistry, 2000, 39, 13005-13011.
58. D. H. Lee, D. R. Jacobs Jr. and M. Porta, Environ. Health Perspect., 2009, 117, 1799-1802.
59. H. Naranmandura, K. Ibata and K. T. Suzuki, Chem. Res. Toxicol., 2007, 20, 1120-1125.
60. T. Ochi, K. Kita, T. Suzuki, A. Rumpler, W. Goessler and K. A. Francesconi, Toxicol. Appl. Pharmacol., 2008, 228, 59-67.
61. H. Stopper, I. Eckert, P. Wagener and W. A. Schulz, Recent Results Cancer Res., 1997, 143, 183-193.
62. A. Eden, F. Gaudet, A. Waghmare and R. Jaenisch, Science, 2003, 300, 455.
63. F. Gaudet, J. G. Hodgson, A. Eden, L. Jackson-Grusby, J. Dausman, J. W. Gray, H. Leonhardt and R. Jaenisch, Science, 2003, 300, 489-492.
64. T. Ramirez, H. Stopper, R. Hock and L. A. Herrera, Mutat. Res., 2007, 617, 16-22.
65. WHO, Arsenic and arsenic compounds, World Health Organization, Geneva, 2001.
66. R. Raml, A. Rumpler, W. Goessler, M. Vahter, L. Li, T. Ochi and K. A. Francesconi, Toxicol. Appl. Pharmacol., 2007, 222, 374-380.
67. J. Scheer, S. Findenig, W. Goessler, K. A. Francesconi, B. Howard, J. G. Umans, J. Pollak, M. Tellez-Plaza, E. K. Silbergeld, E. Guallar and A. Navas-Acien, Anal. Methods, 2012, 4, 406-413.